NCT02862678View on ClinicalTrials.gov

Predictive Value of Diffusion-weighted MRI Performed in Early Post-treatment in the Occurrence of Tumor Recurrence or Progression in Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy: a Pilot Study

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 23, 2019

Study Completion Date

April 23, 2019

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
OTHER

diffusion-weighted MRI

Two diffusion-weighted MRI will be performed (one 8 days before chemoradiotherapy treatment and one 3 months after the end of chemoradiotherapy treatment).

Trial Locations (1)

51092

Chu de Reims, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER

NCT02862678 - Predictive Value of Diffusion-weighted MRI Performed in Early Post-treatment in the Occurrence of Tumor Recurrence or Progression in Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy: a Pilot Study | Biotech Hunter | Biotech Hunter